Erythrina burttii
Erythrina burttii · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Erythrina burttii is a botanical species that has gained attention for its significant pharmacological potential. Scientific investigations have identified key bioactive chemicals within the plant, including 3-O-Methylcalopocarpin, 5,2',4'-trihydroxy-7-methoxy-6-(3-methylbut-2-enyl)isoflavone, 7-O-Methylluteone, and 8-prenylluteone. These compounds are primarily concentrated in the root and stem sections of the plant. Researchers specifically focus on preparations derived from the root bark and stem bark to study their medicinal properties. Current studies suggest that these extracts may hold therapeutic promise in the treatment of conditions such as cancer and leukemia.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Not available
- Plant Parts
- Root · Stem
Classification
Common Names
Erythrina burttii is a striking plant that is widely recognized by its local common name, rohtokorallipuu. This beautiful species is often celebrated for its vibrant floral displays that draw significant attention in its native habitat. By understanding its common identity, gardeners and botanists can better appreciate its unique place within the ecosystem. The name itself serves as a helpful bridge between scientific classification and traditional cultural knowledge. Ultimately, learning about this relationship helps foster a deeper connection to the diverse world of tropical flora.
Sources: Catalogue of Life (COL)
Taxonomy
Erythrina burttii is a fascinating botanical specimen that belongs to the kingdom Plantae. Within this vast kingdom, the plant is classified under the class Equisetopsida. It further refines its biological identity as a member of the order Fabales. This specific order leads it into the prominent family Fabaceae, a group known for its diverse characteristics. Ultimately, this species is identified by its unique genus, Erythrina.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Erythrina |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Erythrina burttii is a distinctive plant species with a specific geographic range concentrated within the African continent. Its distribution primarily spans the diverse landscapes of East Tropical Africa, including the nation of Kenya. Additionally, this species can be found throughout various regions of Tanzania, thriving in its local environment. The plant also extends its reach into Northeast Tropical Africa, specifically within the borders of Ethiopia. Together, these locations highlight the specialized ecological niche that Erythrina burttii occupies across the eastern reaches of Africa.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Compounds
Erythrina burttii serves as a significant source of various chemical compounds found within its stem bark. Detailed spectroscopic analysis has led to the isolation of several specific isoflavonoids and flavanones from this plant. Specifically, researchers identified the presence of 3-O-methylcalopocarpin, genistein, and 8-prenylluteone. The study also highlighted the discovery of two new compounds, namely 7-O-methylluteone and burttinonedehydrate. Together, these findings expand the known chemical profile of this unique botanical species.
Conditions
Erythrina burttii demonstrates significant potential in the medicinal management of cancer and related diseases. Specifically, the root bark of this plant has shown inhibitory effects against human leukemia cells. When extracted using a combination of dichloromethane and methanol, the plant exhibited more than 50% cell inhibition at a concentration of 10μg/mL. These findings support its traditional use as a treatment for leukemia within Kenyan communities. Such cytotoxic activity reinforces the role of Erythrina burttii in addressing these specific malignant conditions.
Preparations
Erythrina burttii is prepared as root bark for use in pharmacological studies involving extracts from various Kenyan medicinal plants. In these investigations, the root bark of this species is specifically extracted using a 50% CH2Cl2-MeOH solvent system to test for cytotoxicity against leukemia cells. Additionally, Erythrina burttii is prepared as stem bark for the isolation of specific chemical compounds. Researchers have successfully identified two new prenylated flavonoids, 7-O-methylluteone and burttinonedehydrate, from the stem bark of this plant. These distinct preparation methods allow for both the assessment of medicinal potential and the discovery of new isoflavonoids.
Parts used
Erythrina burttii is a plant species that contains various bioactive components within its anatomical structures. Scientific investigations have identified that the root bark of this species possesses significant cytotoxic properties against leukemia cells. Furthermore, the stem bark serves as a valuable source for the isolation of unique chemical compounds, including new isoflavones and flavanones. By analyzing both the root and stem parts, researchers can better understand the plant's complex phytochemical profile. These findings highlight the medicinal potential inherent in different parts of Erythrina burttii.